About Merieux Equity Partners
Merieux Equity Partners is a company based in Lyon (France). It operates as a B2B. Merieux Equity Partners has completed 7 acquisitions, including Curea medical, Doc Generici and InnoSyn.
- Headquarter Lyon, France
-
Sectors
Financial Services
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Curea medical
& 6 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Merieux Equity Partners
Unlock access to complete
Funding Insights of Merieux Equity Partners
Investments & Acquisitions by Merieux Equity Partners
Merieux Equity Partners has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Curea medical, Doc Generici and InnoSyn.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Provides research and development of chemical processes
|
2017 | ||||
|
Wound dressing solutions are developed using supercore technology.
|
2010 | ||||
|
Food supplements are distributed by NUTRAGROUP in the French market.
|
2008 |
Financial Statements - Merieux Equity Partners
Merieux Equity Partners Comparisons
Competitors of Merieux Equity Partners
Latest news on Merieux Equity Partners
Frequently Asked Questions about Merieux Equity Partners
Merieux Equity Partners is headquartered in Lyon, France. It is registered at Lyon, Auvergne-rhone-alpes, France.
Merieux Equity Partners is headquartered in Lyon, France, where operations as a private equity firm are conducted. Focus is placed on healthcare and nutrition sectors, with investments directed toward biotech, diagnostics, and related sub-sectors. High-potential companies are supported through capital provision and operational guidance to facilitate development and expansion across Europe and beyond.
Merieux Equity Partners has made 7 acquisitions, including Curea medical, Doc Generici, and InnoSyn.